← Evidence map

ArticleBiomedicines2024

T Cell Receptor-Directed Bispecific T Cell Engager Targeting MHC-Linked NY-ESO-1 for Tumor Immunotherapy.

Yiming Li et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

1 paper cites it

2024
this papercites it
Full record →Abstract, authors, funding and every citing paper · PMID 38672132